Overview

Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out more about how PV-10 works in melanoma tumors. Researchers also want to find out if there are changes in the body's immune cells (cells that fight infection and illnesses) after PV-10 is given, both inside the melanoma tumors and circulating in the blood.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborator:
Provectus Pharmaceuticals